- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
House Floor Next for Contentious GOP Budget Plan That Cuts Social Safety Net, Tax Rates
It’s on to the House floor for a deficit-slashing GOP budget plan.
That’s the next step after the House Budget Committee approved the bold but contentious blueprint by a near party-line vote late Wednesday.
Republican leaders may have a tougher time corralling the votes to pass the measure through the full House, where some tea party conservatives think it doesn’t go far enough, even though it calls for cutting $5.3 trillion from President Barack Obama’s budget over the coming decade, including sweeping cuts to federal health care programs and social programs aimed at the poor.
Read the full story: http://hcp.lv/GEFI4f
Source: The Washington Post
Streamlining "Brain-to-Vein" Time, Patient Selection, Imperative for Implementing CAR T for MM
March 21st 2025Ajai Chari, MD, University of California San Francisco, explores the challenges that accompany integrating chimeric antigen receptor (CAR) T-cell therapies into multiple myeloma treatment.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Overcoming CAR T Manufacturing Failure in LBCL
March 21st 2025Data incorporated for this study were collected from 9 centers in the UK focused on third-line and beyond chimeric antigen receptor (CAR) T-cell administration in patients with relapsed/refractory large B-cell lymphoma (LBCL).
Read More
